Finance

Beta
Lists
CRBP:NASDAQ
Corbus Pharmaceuticals Holdings Inc
$9.07
-3.30%
(-0.31) 1D
$9.07
0.00% (0.00)
After hours
Closed: Jul 1, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRBP...
Open
$9.29
High
$9.45
Low
$8.99
Mkt. cap
168.05M
Avg. vol.
693.50K
Volume
442.20K
52-wk high
$20.56
52-wk low
$7.12
EPS
-$5.81
Beta
2.57
Shares outstanding
18.53M
No. of employees
36
Open
$9.29
High
$9.45
Low
$8.99
Mkt. cap
168.05M
Avg. vol.
693.50K
Volume
442.20K
52-wk high
$20.56
52-wk low
$7.12
EPS
-$5.81
Beta
2.57
Shares outstanding
18.53M
No. of employees
36
News stories
From sources across the web
About Corbus Pharmaceuticals Holdings Inc
CEO-
Employees36
FoundedJan 1, 2009
Headquarters-
SectorBiotechnology
Websitecorbuspharma.com
Analyst ratings
Based on 10 analysts giving stock ratings to CRBP in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for CRBP in the last 3 months.
Highest
Current $9.07
$52.00 (+473.32%)
Average
$37.33 (+311.58%)
Lowest
$28.00 (+208.71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Graig Suvannavejh
Mizuho Securities
Buy
Maintained
$34.00
+274.9%
06/23/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
$52.00
+473.3%
06/17/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
$54.00
+495.4%
06/02/2026
Paul Jeng
Guggenheim
Buy
Maintained
$45.00
+396.1%
06/02/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
$40.00
+341%
06/02/2026
Andy Hsieh
William Blair
Buy
Maintained
-
-
06/01/2026
Robert Driscoll
Wedbush
Buy
Reiterated
$30.00
+230.8%
05/27/2026
Oliver McCammon
LifeSci Capital
Buy
Maintained
$38.00
+319%
05/26/2026
Brian Abrahams
RBC Capital
Buy
Maintained
$36.00
+296.9%
05/26/2026
Unknown Analyst
Wedbush
Buy
Reiterated
$38.00
+319%
05/13/2026
Maury Raycroft
Jefferies
Buy
Maintained
$33.00
+263.8%
05/12/2026
Unknown Analyst
B. Riley Securities
Buy
Reiterated
$28.00
+208.7%
04/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
15.19M
20.86M
18.41M
19.82M
Cost of revenue
15.19M
20.86M
18.41M
19.82M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.96M
3.56M
3.56M
4.48M
Operating expense
3.96M
3.56M
3.56M
4.48M
Total operating expenses
19.15M
24.42M
21.97M
24.30M
Operating income
-19.15M
-24.42M
-21.97M
-24.30M
Other non operating income
176.00K
-50.00K
-1.10M
-67.00K
EBT including unusual items
-17.66M
-23.34M
-20.56M
-22.97M
EBT excluding unusual items
-17.66M
-23.34M
-21.66M
-22.97M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.66M
-23.34M
-20.56M
-22.97M
Net profit margin
-
-
-
-
Earnings per share
-1.44
-1.90
-1.25
-1.23
Interest and investment income
1.31M
1.12M
1.41M
1.40M
Interest expense
-
-
-
-
Net interest expenses
1.31M
1.12M
1.41M
1.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
-19.10M
-24.37M
-21.92M
-24.26M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer